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Abstract: The domestic cat is afflicted with multiple viruses that serve as powerful models 
for human disease including cancers, SARS and HIV/AIDS. Cat viruses that cause these 
diseases have been studied for decades revealing detailed insight concerning transmission, 
virulence, origins and pathogenesis. Here we review recent genetic advances that have 
questioned traditional wisdom regarding the origins of virulent Feline infectious peritonitis 
(FIP) diseases, the pathogenic potential of Feline Immunodeficiency Virus (FIV) in wild 
non-domestic Felidae species, and the restriction of Feline Leukemia Virus (FeLV) 
mediated immune impairment to domestic cats rather than other Felidae species. The most 
recent interpretations indicate important new evolutionary conclusions implicating these 
deadly infectious agents in domestic and non-domestic felids. 
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1. Introduction  
The aloof and elusive nature of domestic cats, Felis catus, the world’s most popular pet, is 
endearing to some and exasperating to others. Including feral cats, there are 600 million to one billion 
domestic cats worldwide, an astounding number for an animal that contributes little to nothing in the 
way of work, milk or meat to the human endeavor. The domestic cat is the consequence of a 
remarkable domestication experiment that commenced in near east Asia some 10,000 years ago, when 
the shy and reclusive desert wildcat (Felis sylvestris) gradually morphed into the venerated, audacious, 
and familiar human pet. Domestication processes began when Neolithic hunter-gatherers settled in 
agricultural villages in a rich area of the Middle East we call the Fertile Crescent. These first farmers 
cultivated wild precursors of corn, wheat and barley, while others herded and penned cattle, sheep, 
goats and even pigs. The domestication strategy fed and clothed many more people than hunters could 
support. Contemporaneously, the wildcats fed on scraps, befriended the settlers and began a legacy of 
human companionship that is unprecedented in human civilization [1]. 
At first glance, the major benefit of cat domestication appears to be human companionship, but this 
role is rapidly expanding to encompass issues in human health. Viral infectious diseases in cats have 
patterns of evolution, virulence and pathogenicity that offer strong parallels to related viruses in 
humans (Table 1). Feline coronavirus (FCoV), common in domestic cats, is a close relative of the 
human SARS coronavirus that afflicted the world in 2003, when a reported 8096 infections 
in 23 countries killed 774 people before the outbreak subsided [2]. In the 1960’s, the discovery of 
feline leukemia virus and its ability to recombine with host cellular oncogenes resulted in a better 
understanding of numerous feline and human malignancies [3]. Feline Immunodeficiency Virus (FIV), 
first identified in 1986 as the causative agent of an AIDS-like syndrome in a California cat colony[4], 
remains a compelling natural model of immunodeficiency pathogenesis, mirroring the HIV-AIDS 
epidemic that has dominated the past human generation. Add to that feline calicivirus, feline herpes 
virus, feline foamy virus and panleukopenia parvovirus; cat species provide a panoply of infectious 
disease models for many devastating human diseases (Table 1). 
Table 1. Examples of domestic cat viruses with human homologues *.  
Feline Virus Human Homologue 
Feline Leukemia Virus (FeLV) [5] Human T-Cell Leukemia Virus (HTLV) [6] 
Feline Immunodeficiency Virus (FIV) [7] Human Immunodeficiency Virus (HIV-AIDS) [8] 
Feline Coronavirus (FCoV) [9] SARS-Coronavirus (Severe acute respiratory syndrome) [10]
Feline Sarcoma Virus (FSV) [11] ~20 Human Oncogenes [12] 
Avian H5N1 Influenza [13] Avian H5N1 Influenza [14] 
Feline Herpes Virus (FHV) [15] Cytomegalovirus (CMV-retinitis) 
Feline Foamy Virus  (FFV) [16] Human Foamy Virus (No pathology) [17] 
Feline Calicivirus (FCV) [18] Human Calicivirus (Diarrhea, vomiting) [19] 
Feline Parvovirus (FPV) [20] Human B19 Parvovirus (Fifth disease) [21] 
Feline Morbillivirus (CDV) [22] Human Morbillivirus (Measles) [23] 
* Many references exist for each virus in both cat and human, here we provide single references as examples. 
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In this review, we will attempt to highlight how recent advances in our understanding of three cat 
viruses (FCoV, FIV, and FeLV) have revised conventional wisdoms. We illustrate how previous 
tenets, based on limited available evidence, were revised and amended due to new insights from 
genetic studies of cat populations. 
2. Feline Coronavirus (FCoV) Pathogenesis in Domestic Cats 
Feline infectious peritonitis (FIP) is a fatal, progressive, and immune-augmented disease of cats 
caused by infection with feline coronavirus (FCoV). Coronaviruses are enveloped positive-stranded 
RNA viruses that infect a wide range of vertebrate species [24]. The clinical manifestation of FCoV 
infection can present either as the pathogenic disease manifestation or feline infectious peritonitis virus 
(FIPV) or the more common, benign or mild enteric infection (feline enteric coronavirus—FECV—
asymptomatic) [25,26]. Although FCoV is common in domestic, feral and non-domestic cat 
populations world-wide (seroprevalence from 20–100%), less than 10% of FCoV seropositive cats 
develop FIP [27-29]. Cats infected with FCoV that show no evidence of disease are thought to 
represent chronic carriers of FCoV and may pose an FIP risk to other cats [27,30,31].  
FIP pathology is characterized typically by severe systemic inflammatory damage of serosal 
membranes and widespread pyogranulomatous lesions, occurring in lung, liver, lymph tissue, and 
brain [32]. Evidence suggests that the host immune system is crucial in this pathogenesis; both 
profound T-cell depletion from the periphery and lymphatic tissues and changes in cytokine expression 
are observed in end stage FIP [33,34].  
Viral gene determinants likely play an important role in FCoV pathogenicity and virulence. 
Coronaviruses are a large family of enveloped, single stranded, positive sense, non-segmented RNA 
viruses. Characterized by a genome size roughly 30 kb in length, coronaviruses are the largest RNA 
virus so far described [35]. However, there is no effective treatment, vaccine, nor a diagnostic protocol 
that can discriminate the avirulent FECV from the pathogenic FIP strains.  
Conventional wisdom accepts the “in vivo mutation transition hypothesis” also called the “internal 
mutation hypothesis” which postulates that viral mutations occur in healthy FCoV infected cats giving 
rise to virulent virions that spread systemically and lead to FIP pathogenesis [36,37]. Although this 
hypothesis has been widely cited [9,25,27,30,31,36–39] the precise nature of the mutation responsible 
for pathogenesis has never been identified. Various studies have speculated that variants in the spike 
protein, membrane protein, or NSP 3c [40] allow infection of macrophages, systemic dissemination, 
and fatal disease manifestation [36,37].  
An alternative “circulating avirulent and virulent FCoV hypothesis” suggests that distinctive benign 
and pathogenic strains of FCoV circulate in a population, and those individuals exposed to the virulent 
strains, with the appropriate predisposition, develop disease sequelae. Virological precedence for this 
possibility has been reported for dengue fever virus and equine Venezuelan encephalitis virus, both of 
which demonstrate circulating virulent and avirulent forms [41,42].  
To test between these alternatives, Brown et al. compared the FCoV gene sequence patterns among 
FIP afflicted cats and FCoV infected asymptomatic cats collected from households in Maryland 
between 2004 and 2006 [43]. Brown et al. [43] reasoned that a phylogenetic analysis of virogene 
sequences would be informative in discriminating between the two hypotheses as follows: if the 
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“circulating virulent-avirulent FCoV hypothesis” were the case, then a “monophyletic” pattern of 
FCoV variation would cluster pathogenic cats separately from healthy cats, since a circulating 
pathogenic virus would have accumulated mutations over time to drift apart from the avirulent FCoV 
strain. Alternatively if the “in vivo mutation hypothesis” were the case, then FCoV from healthy and 
sick cats would cluster together (paraphyletic inter-mixing) in accordance with geographic locale 
(i.e., phylogeographic clustering), and not pathogenic virulence. 
Brown et al. [43] inspected the phylogenetic clustering of four FCoV genes (pol replicase; spike, 
membrane and NSP 7b; Figure 1) in 56 cats (8 FIP and 46 healthy) from Maryland catteries. The 
results, illustrated by the phylogenetic analysis in Figure 1, were definitive in clustering the virus from 
sick FIPV cats together in a monophyletic group, quite distinctive from the FCoV derived from the 
healthy cats. In one cat (FCA-4590) that progressed from a healthy FECV positive state to FIP disease 
over the course of two years, the recovered virus from the earlier time point clustered with other FCoV 
-innocuous strains while the virus isolated when the cat showed disease symptoms clearly grouped 
with genetically distinct virulent FIP strains, as if the innocuous FCoV were replaced by a second 
virulent FIPV strain (Figure 1).  
Brown et al. [43] interpreted these results as supporting the concept that there were at least two 
distinctive circulating forms of FCoV in Maryland, one which caused FIP, and a second that did not. 
Further, they identified certain amino acid signatures of the membrane gene that were diagnostic of 
FIPV versus avirulent circulating FCoV in the feral cat population. Although these results would tend 
to support the circulating variant explanation, they need to be replicated and extended to other 
geographic locales to accurately reflect variation possible in the world’s 700 million cats. One recent 
study documented paraphyly (mixing) of FIP and healthy FCoV infected cat strains in Europe, which 
would seem to complicate the interpretation [44]. Thus, current evidence would suggest that FIP 
etiology is more complex than either hypothesis alone would suggest. Perhaps the causative mutation 
has not been found because multiple mutations may result in increased pathogenicity. It is also 
possible that some strains are more prone to these mutations than others; a situation that would mimic 
the circulating avirulent and virulent hypothesis, as well as explain the results seen in Brown et al. 
Future studies exploring both viral and host genetic determinants of disease in FIP [45,46], should 
reveal opportunities for the management of this disease including the possible development of ante 
mortem screening tools for genetic disposition for disease as well as the discrimination of virulent 
versus avirulent strains of FCoV. 
3. Feline Immunodeficiency Virus: FIV Pathogenesis in Felidae Species  
Feline Immunodeficiency Virus (FIV) was first discovered 25 years ago [4,47] as a cat lentivirus 
with structural, genomic, and pathogenic parallels to HIV [48–50]. Infected domestic cats develop 
symptoms of immune depletion including a precipitous drop in CD4 bearing T-lymphocytes, 
neutropenia, lymphadenopathy and susceptibility to normally harmless bacteria, fungal lesions, 
wasting, and rare cancers. FIV is endemic in feral cat populations and has diverged into several 
phylogenetic clade types across the world [51–55].  
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Figure 1. Phylogenetic tree of cloned feline infectious peritonitis (FIP) membrane 
sequences (655 bp) from 19 healthy (feline enteric coronavirus (FECV); green) and 8 
symptomatic (feline infectious peritonitis virus FIPV; red) cats [43]. One cat, Fca-4590, 
was sampled when healthy and then at death caused by FIP. Shown is the maximum 
likelihood tree constructed from 655 bp of the membrane gene. The number of FECV and 
FIP cases followed by the number of cloned sequences is indicated in parenthesis. The 
labels for each sequence include location W, Weller Farm; F, Frederick Animal Shelter; S, 
Seymour Farm; M, Mount Airy Shelter; A, Ambrose Farm), 4-digit cat identification 
number, tissue source (fe, feces; af, ascites fluid; co, colon; li, liver; sp, spleen; in, 
intestine; je, jejunum; ln, lymph node), 2-digit year (e.g., 04 = 2004), and number of clones 
for each sequence. Bootstrap values are shown (MP/minimum evolution/ML) above 
branches. Where ML tree was congruent with MP tree, branch lengths are indicated below 
branches; the number of homoplasies is in parenthesis after the branch length. Virus 
sequence obtained from cat no. 4590 in May 2004 and at the time of death due to FIP in 
December 2004. The transitional individual serial samples are indicated with open circles 
(first sample) and solid circles (second sample). Scale bar indicates substitutions/site.  
	
 
FIV has infected many of the 37 described species of the Felidae family [56] (Table 2). It is 
speculated that most cat species (Table 2) acquired the virus within the last 10–20,000 years, but 
patterns of evolution within both virus and host genomes, suggest FIV may have existed far longer in 
some species such as lion [57,58]. Phylogenetic analysis of individual FIV-isolates in a dozen or more 
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species of felids [7,58–61] demonstrates reciprocal monophyly of FIV among various species (that is, 
every lion strain has as its closest relative another lion isolate rather than FIV from a different cat 
species) (Figure 2). These phylogenetic results supported the notion that although FIV occasionally 
can move from species to species [62–64], these events are exceedingly rare, leading to a 
monophyletic expansion of viral genome sequence diversity within every species, so that most cat 
species carry their own distinct version of FIV [65–68]. 
Table 2. Summary of FIV prevalence tested by western blot (AB) and PCR in Felidae. 
Species Common Name 
Free Ranging Captive 
Citation 
AB+ PCR+ AB+ PCR+ 
Felis silvestris European wild cat 5/125 0/3 4/13  [7,69–72] 
F. libyca African wild cat   1/16 0/1 [7] 
F. bieti Chinese desert cat      
F. margarita Desert cat 0/14  6/13 0/7 [7,69] 
F. nigripes Black-footed cat   3/11 0/4 [7] 
F. chaus Jungle cat   5/17 0/6 [7] 
Otocolobus manul Pallas cat 10/27 7/26 12/19 2/2 [7,43] 
Prionailurus 
rubiginosis 
Rusty spotted cat   0/1  [7] 
P. bengalensis Asian leopard cat 1/12 1/1 0/81  [7,73,74] 
P. viverrinus Fishing cat   1/25 0/2 [7] 
P. planiceps Flat-headed cat 0/2  1/9  [7] 
Puma concolor Puma 150/360 61/123 45/166  [7,61,75–77] 
P. yagouaroundi Jaguarundi   9/40 1/8 [7,78] 
Acinonyx jubatus Cheetah 22/303 7/10 6/242  [7,75,79,80] 
Lynx pardinus Iberian lynx 7/74 0/75   [7,81] 
L. lynx Eurasian lynx   0/10  [7,75] 
L. canadensis Canada lynx 0/92  1/2 0/1 [7,82] 
L. rufus Bobcat 32/115 17/32 1/8 0/1 [7,83] 
Leopardus pardalis Ocelot 8/26 1/14 10/88 0/6 [7,75,78] 
L. wiedii Margay 1/5 1/1 4/88 1/3 [7,78] 
L. jacobita Andean mountain cat      
L. colocolo Pampas cat   1/12  [7] 
L. geoffroyi Geoffroy's cat 1/6 0/1 8/45 0/7 [7] 
L. guigna Kodkod   0/2  [7] 
L. tigrinus Tigrina   3/40 0/2 [7,78]  
Caracal caracal Caracal 0/3  0/22  [7,79] 
C. aurata African golden cat   0/2  [7] 
C. serval Serval   0/4  [7,75]  
Pardofelis badia Bay cat   0/1  [7] 
P. temminckii Asian golden cat 0/1  3/29 0/2 [7] 
P. marmorata Marbled cat   2/10 0/3 [7] 
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Table 2. Cont. 
Species Common Name 
Free Ranging Captive 
Citation 
AB+ PCR+ AB+ PCR+ 
Panthera leo Lion  212/321 72/132 1/1 [7,75,80,84–86] 
P. onca Jaguar  0/2 8/42 0/7 [7,75,78] 
P. pardus Leopard  7/10 1/96 0/1 [7,75,79,80] 
P. tigris Tiger 0/1  25/217 1/12 [7,75]  
P. unca Snow leopard   3/77 1/2 [7,75]  
Neofelis nebulosa Clouded leopard   4/59 0/2 [7] 
Bold numbers = congruence between AB and PCR; shaded = free-ranging “+”; bold letters = PCR 
free-ranging “+” animals. 
Figure 2. Maximum likelihood phylogenetic tree of 72 non-identical FIV from seven 
carnivore species based on a region of pol-RT (420 bp) [7,58,65]. Circles indicate subtypes 
within FIVPle, FIVPco and FIVFca lineages. 
 
 
Originally, the absence of clear clinical pathology among FIV infected felids in zoological 
collections, and field observations of seemingly healthy (or asymptomatic) FIV in natural populations 
of felids fostered the view that FIV is pathogenic in domestic cats but not in other free ranging species 
of Felidae [60,87]. However, that conclusion now seems premature and over-simplified. For example, 
Roelke et al. [88]. mounted a detailed physical examination and associated clinical measures among 64 
free ranging lions in Botswana and Tanzania between 1999 and 2006. They examined a suite of 
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biochemical, clinical, and pathogenic manifestations of immune suppression and disease analogous to 
pathogenesis observed in FIV infected domestic cats, in HIV-infected AIDS patients and in simian 
immunodeficiency virus (SIV)-infected macaques (see citations [88]).  
Multiple indications and sequelae of AIDS defining conditions were manifest amongst FIV infected 
lions compared to FIV negative lions; the statistical associations are summarized in Table 3. First, a 
marked depletion of CD4 bearing T lymphocytes was apparent in FIV infected lions, a prelude 
to immune collapse in well defined AIDS [88,89]. In addition there were multiple elevations 
in opportunistic infections (papilloma, gingivitis, dehydration during wet conditions, anemia, 
hyperalbuminemia, weight loss in the face of abundant prey, abnormal red cell parameters, depressed 
serum albumin, liver pathogenesis, and elevated gamma globulin). Further, spleen and lymph node 
biopsies from nine free ranging lions revealed evidence of lymphoid depletion, the hallmark of AIDS 
disease in human, cats and macaques. These findings strongly suggest FIV is contributing to the loss of 
immune competence in these lions. A similar pathogenic study of wild SIV-infected chimpanzees also 
revealed definitive evidence of pathology in that species after a decade of pronouncing chimps as 
resistant to SIV [90]. 
As most people infected with HIV do not actually die of HIV infection per se, rather from 
subsequent opportunistic infections (e.g., pneumocystis, CMV, Kaposi’s sarcoma, candidiasis and 
other infections) it seemed fair to ask whether FIV in large cats might contribute to secondary infection 
pathogenesis. An opportunity to inspect this occurred during the mid-1990s in Tanzania when an 
outbreak of canine distemper virus (CDV; a morbillivirus) eliminated ~1000 lions from the large 
Serengeti populations in a 10 month interval [91]. Because FIV prevalence in East African and 
Botswana lions approaches 100% in adults, the potential influence of FIV on CDV pathology was to us 
an interesting question. 
Lions harbor six genetically distinct strains, or subtypes, of lion FIV (FIVPle) resolved by 
phylogenetic analyses [57,58] (Figure 2). These strains have distinct phylogeographic distributions, 
suggesting prolonged host association, perhaps predating the Late-Pleistocene expansions of lions 
roughly 325,000 years ago [57]. Two lion FIVPle strains, FIVPle E and FIVPle A, circulate in Botswana; 
while three very divergent strains FIVPle A, B, and C occur in the Serengeti [92,93]. Perhaps 
consequent of the highly social nature of lions, FIVPle infected lion populations have high prevalence 
of seropositive individuals, approaching 100% in adult animals [7,57,92] (Figure 3a).  
Troyer et al. [94] recently examined the association of FIV strains with relative survival (from 
death) in the Serengeti lions during the CDV outbreak. A rather striking difference was seen in that 
FIVPle B infected lions were twice as likely to survive CDV compared to lions infected with alternative 
strains FIVPle A and FIVPle C (Figure 3b). The apparent FIVPle B associated protective influence was 
evident whether individuals were infected with a single strain or with multiple strains (Figure 3b). 
These observations would suggest that infection with FIVPle A or C might have increased the risk of 
mortality upon secondary CDV infection. This inference that certain FIVPle strains predispose carriers 
to CDV pathogenesis has some parallels with FIV strain-specific pathogenicity in domestic cats [95–97]. 
Further, the higher CDV mortality among of FIVPle A and C carrying individuals actually altered FIV 
strain incidence causing a rise in FIVPle B and a drop in FIVPle C during the course of the CDV 
outbreak (Figure 3c). 
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Table 3. Medical conditions present in HIV, SIV and FIV infections found in FIVPle infected wild lions compared with FIVPle negative lions. 
(Adapted from [48]). 
Medical Condition 
FIVPle Negative FIVPle Positive Odds Ratio P Value 
% Affected # Individuals % Affected # Individuals 
Immunodeficiency       
CD4 depletion Absolute number of CD4+ T-cells /mL in peripheral whole blood ±s.e. 0 5 100 8 NA 0.00015 
Oral manifestations       
Gingivitis 40 15 88.4 43 11.4 0.00016 
Papillomavirus 14.3 14 53.19 47 6.82 0.01009 
Chronic Inflammatory Response       
Lymphadenopathy 41.67 12 76.6 47 4.58 0.01900 
Hyperglobulinemia 0 14 85.71 46 NA <2 × 10−9 
Erythrocyte sedimentation rate 13.33 15 64.86 37 12 0.00076 
(> 2 s.d. above mean)       
Dehydration (> 4%) 26.67 15 63.04 46 4.69 0.01408 
Loss of Condition and Under Nutrition       
Hair and coat abnormalities 13.3 15 52.27 44 7.12 0.00840 
Hypoalbuminemia (marker of cachexia) (serum albumin > 2 s.d. below mean)  0 14 46.94 46 NA 0.00129 
Anemia (hemoglobin / PCV >2 s.d. below mean) 11.11 18 55.77 52 10.09 0.00101 
Cachexia/unexplained weight loss Not documented Observed in 3 FIV+ populations NA NA 
Lymphoid response evidence       
Histopathologic evidence: Lymphoid activation Not documented Yes  NA NA 
Histopathologic evidence: Lymphoid atrophy & depletion Not documented Yes  NA NA 
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Figure 3. Distribution, incidence and co-infection of canine distemper virus (CDV) and 
FIV in Serengeti lions. (a) Map of approximate pride home ranges during the CDV 
outbreak in April of 1994. Distribution of FIVPle subtypes by pride is shown here [87,93]. 
(b) Comparison of survival between lions with (dark grey) and without (light grey)  
FIVPle-B. Shown here are Chi-squared p-values. Fisher’s exact two-tailed statistics are 
significant all subtype configurations (p = 0.028) and approaching significant for single 
subtype infection (p = 0.072). (c) FIVPle subtype distribution over time. Lions that were 
alive at the beginning of the CDV outbreak (N = 91) were sampled either prior to April 
1994, during the month of April 1994, or after April 1994. Most of the 1994 sampling 
occurred in April after the peak mortality (approximate time shown here as a grey bar). 
Knowledge of subtype frequencies prior to April 1994 is primarily from samples collected 
from those animals in previous years. These regressions are significantly different 
(p = 0.001).  
a 
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Figure 3. Cont. 
b 
 
c	
 
 
The statistical rigor associated with these conclusions is rather weak since the number of lions was 
limited (total = 119 lions) and should be interpreted cautiously. Nonetheless, the striking influence of 
FIV on lion immune function (Table 3), clinical disposition, and a potential ancillary role in CDV 
mortality (Figure 3b,c) affirms that FIV is likely pathogenic in lions. However, the degree to which 
viral pathogenicity is influenced by host genomics underlying the immune response, the role of 
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secondary infections, stochastic events due to ecological and environmental factors, has yet to be 
described. Nonetheless, FIV is a potentially harmful agent in free ranging lions, as for housecats, and 
deserves further scrutiny in the other free ranging species afflicted with FIV [88,94].  
4. FeLV Outbreak in Free Ranging Florida Pumas 
Feline leukemia virus, a retrovirus of domestic cats, displays a prevalence of 1–8% among feral 
cats worldwide. Transmission is usually by direct contact, and outcome after exposure depends on 
several host and viral factors. In approximately one third of exposed cats, viremia is persistent and 
eventually results in clinical syndromes including some combination of immunosuppression, anemia 
and/or neoplasia [5,98]. Mortality among persistently infected domestic cats is high as 83% die 
within 3.5 years [99]. 
Like other Type C retroviruses, FeLV induces immune suppression making the cats susceptible to 
opportunistic infections and cancers. There are four naturally occurring exogenous FeLV strains 
FeLV-A, -B, -C, and -T, that are distinguished genetically by sequence differences in the env gene and 
by receptor interactions required for cell entry [100]. FeLV-A is the predominant subgroup circulating 
in feral cats and is often only weakly pathogenic [101]. The endogenous feline leukemia provirus 
sequences are transmitted vertically though the germ line as integrated provirus nested on several cat 
chromosomes. Among infected cats the pathogenic subgroups, FeLV-B, -C, and -T, are generated 
de novo by mutation or recombination in the env region between exogenous subgroup A virus and 
endogenous proviral sequences [5,102–104]. 
FeLV infection among non-domestic cats of the Felidae family is rare. Most reported infections 
involved captive animals that acquired FeLV by physical contact with FeLV-infected domestic cats, 
and in nearly all cases that were followed, the virus was cleared by the infected individuals [105,106]. 
Therefore, it was postulated that FeLV pathogenicity did not occur in exotic felids, simply because 
there were no endogenous FeLV present in species outside the domestic cat lineage. The outcome with 
a Florida panther FeLV outbreak in 2001–2006 was unexpected and served to change this hypothesis 
[105,107]. 
The Florida panther (Puma concolor coryi) is an endangered subspecies whose range was 
contiguous with other puma populations [108]. By the late 20th century, however, depredation, 
exploitation, human population growth and habitat destruction had reduced the population to an 
isolated relict population of fewer than 30 individuals [109]. In 1995, a Florida panther restoration 
management action relocated eight Texas cougars (Puma concolor stanleyii) to the Florida habitat in a 
hopeful rescue of the threatened subspecies. The population rebounded to over 100 individuals, 
doubling panther numbers, density, survival parameters and fitness [110–112]. 
Florida panthers have undergone continued surveillance from 1978 -2001 and routinely tested for 
several pathogens, including FeLV [105]. However, for the first time in early 2001, 23 panthers were 
discovered to carry antibodies for FeLV by ELISA that was confirmed by Western Blot. Clinical 
symptoms including lymphadenopathy, anemia, septicemia and weight loss rapidly appeared. Five 
panthers shown to carry FeLV antigens in their sera subsequently died of diseases compatible with 
FeLV etiology [105,107]. 
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The rapid appearance and spread of FeLV in this Florida panther population was unprecedented 
among large cats and caused concern in the Felidae conservation community. FeLV was not thought to 
cause serious disease in species other than in cats closely related to domestic cats (F. catus, 
F. sylvestris, F. margarita, F. nigripes and F. bieti) because only these Felis species carry endogenous 
FeLV sequences in their genome, a prerequisite for in situ development of recombinant and virulent 
FeLV strains [5,102,103,113]. 
To explore the origins and the unusual virulence of the emerging FeLV strain in pumas, 
Brown et al. [107] obtained infectious FeLV gene sequence (LTR and env genes; 2851 bp) from 
several FeLV-infected Florida panthers. Alignment and phylogenetic analysis of panther FeLV gene 
sequences and those from known domestic cat FeLV strains revealed three important aspects: (1) The 
panther FeLV was clearly aligned with FeLV domestic cat type FeLV-A, the strain that is largely 
avirulent until after recombination with endogenous sequences; (2) There was no evidence of 
endogenous FeLV sequences within in the panther FeLV; and (3) The panther FeLV was closely 
aligned with a highly virulent FeLV from domestic cats, FeLV-945. Although FeLV-9545 is 
considered an FeLV-A strain, it has a distinctive envelop and LTR sequence that are different from 
other FeLV-A strains. FeLV-945 is unusual is that its severe pathogenicity in domestic cats does not 
involve recombination with the endogenous FeLV sequences [114,115]. A vaccination campaign was 
initiated in 2006 and 52 Florida panthers were captured and vaccinated with no major FeLV incidence 
reported to date. 
An interesting corollary to the Florida panther FeLV outbreak is that FIVPco is endemic in this 
population. Two distinctive strains were present in 2001, one from the original authentic Florida 
panther and a second accidentally introduced in 1995 from FIVPco infected Texas cougars. FIV 
incidence in the population was low (~15% in 1999–2000; [107]). By contrast, 13 of 17 panthers tested 
during 2004–2005 in the FeLV-endemic region (76%; Figure 1) were FIV positive [105,107]. This 
apparent elevation in FIV incidence among FeLV afflicted panthers raises the possibility of a role for 
FIV-mediated immune depletion in FeLV pathogenesis. In domestic cats, FIV and FeLV co-infections 
have resulted in conflicting interpretations [116–121].  
The conclusion here is that domestic cat strains of viruses can cross species barriers with potentially 
devastating consequences to fragile wild populations of large felids. In this case, the requirement for 
endogenous FeLV recombination was abrogated and perhaps the resultant virulence was accelerated by 
FIV immune suppression in Florida panthers. As in lions, FIV depletes puma CD4-T lymphocytes [89], 
so the possibility of FIV accessory role is feasible. Unfortunately, a similar outbreak has recently 
occurred in wild populations of Iberian lynx [81], confirming that FeLV is capable of causing disease 
in non-domestic felids, contrary to conventional wisdom. 
5. Conclusions  
Early attempts to characterize the genetics, epidemiology and pathogenicity of feline viruses 
established the following accepted paradigms in viral disease: that fatal FIP resulted from a simple 
single mutation from the benign FCoV; that FIV was host-adapted and innocuous in non-domestic 
felids; and that FeLV-related disease could only occur in species within the domestic cat lineage and 
always resulted from recombination with endogenous FeLV. However, recent studies augmented by 
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technological advances as well as increased surveillance of free-ranging cat species are revising these 
perceptions. FCoV strains may have different virulence, pathogenicity, and predisposition to FIP 
causing mutations; etiologies may be complex and different in different areas, cats may harbor 
multiple strains throughout their life, and diagnostic genetic profiles may someday be available. FIV in 
wild African lions, once considered benign, is causally linked with AIDS-related symptoms in some 
individuals, and some strains may increase susceptibility to co-infection and mortality. Fragile relic 
populations of Florida panther and Iberian lynx, once thought immune to domestic cat FeLV, are 
highly susceptible to certain strains that are able to emerge in new host species. Thus, several 
conventional paradigms have been unseated by recent studies of virus-host interactions in the wild. 
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